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Abstract The in vitro and in vivo performance of hydro-
xyapatite (HAp) coatings can be modiﬁed by the addition of
different trace ions, such as silicon (Si), lithium (Li), mag-
nesium (Mg), zinc (Zn) or strontium (Sr) into the HAp
lattice, to more closely mirror the complex chemistry of
human bone. To date, most of the work in the literature has
considered single ion-substituted materials and coatings,
with limited reports on co-substituted calcium phosphate
systems. The aim of this study was to investigate the
potential of radio frequency magnetron sputtering to deposit
Sr and Zn co-substituted HAp coatings using Fourier
transform infrared spectroscopy (FTIR), X-ray diffraction
(XRD) and X-ray photoelectron spectroscopy (XPS). The
FTIR and XPS results highlight that all of the Sr, Zn and Sr-
Zn co-substituted surfaces produced are all dehydroxylated
and are calcium deﬁcient. All of the coatings contained
HPO4
2− groups, however; only the pure HAp coating and
the Sr substituted HAp coating contained additional CO3
2−
groups. The XRD results highlight that none of the coatings
produced in this study contain any other impurity CaP
phases, showing peaks corresponding to that of ICDD ﬁle
#01-072-1243 for HAp, albeit shifted to lower 2θ values
due to the incorporation of Sr into the HAp lattice for Ca (in
the Sr and Sr-Zn co-substituted surfaces only). Therefore,
the results here clearly show that RF magnetron sputtering
offers a simple means to deliver Sr and Zn co-substituted
HAp coatings with enhanced surface properties.
Graphical Abstract (a) XRD patterns for RF magnetron
sputter deposited hydroxyapatite coatings and (b)-(d) for Sr,
Zn and Sr-Zn co-substituted coatings, respectively. The
XPS spectra in (b) conﬁrms the presence of a HA sputter
deposited coating as opposed to (c) XPS spectra for a Sr-Zn
co-substituted sputter deposited coating.
1 Introduction
Hydroxyapatite (HAp, Ca10(PO4)6(OH)2) is a highly valu-
able bone repair and regeneration material because of its
similarity to the inorganic phase of human bone. It is
bioactive, osteoconductive and has the ability to form a
direct chemical bond with human bone [1–3]. In addition to
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the bulk form, HAp has been widely used as a coating
material for orthopaedic implants in a variety of applica-
tions, and typically the release of Ca2+ and PO4
3− ions into
the surrounding environment leads to the development of
excellent interfacial strength between the implant and bone
[3–6]. However, chemically pure synthetic HAp has a Ca/P
ratio of 1.67, whereas biological apatite has variable stoi-
chiometry and can contain various different calcium phos-
phate (CaP) phases and ionic substitutions, resulting in a
non-stochiometric multi-element substituted material [7].
As such, when designing CaP biomaterials for clinical use
one proposed route would be to introduce ionic substitu-
tions into HAp in order to mimic the complex chemistry of
human bone and thereby improve the biological perfor-
mance of such materials, both in vitro and in vivo [8, 9].
A wide range of different ions such as Sr, Zn, Ag, Mg,
CO3
2−, F and Si (amongst others) have been strategically
incorporated into the structure of synthetic HAp, replacing
Ca (or PO4
3−), as highlighted in Table 1 [10–48]. The
substitution of such ions into pure HAp alters the crystal
structure (crystallinity and crystal size) and also changes the
properties of the material; namely the thermal and phase
stability, its solubility, surface reactivity and its ability to be
absorbed [49–51]. Particular attention is focused on several
biologically active ions as Zn and Sr, which are naturally
present in native bone tissue and can lead to advantageous
effects on the biological response of osteoblasts. Sr and Zn
both promote the osteoblast response and stimulate forma-
tion of new bone more readily than pure HAp [8, 9, 51, 52].
Sr is a beneﬁcial trace element in human body and is shown
to play an important role in bone formation. Sr stimulates a
range of biological effects on the bone, such as anti-
resorptive activity, osteoclast apoptosis and osteoblast sti-
mulation [6, 8, 9, 49, 53–55]. These effects increase bone
formation and reduce bone resorption, as well as improving
bone strength, bone healing and microarchitecture and
could potentially help in the treatment of osteoporosis [54,
56–58]. Zn is known to be an essential trace element in the
body [9]. Zn is known to stimulate bone formation [8, 9,
59], but it also inhibits bacterial growth at the surgical site
and improves the wound healing process [8, 52]. In addi-
tion, Zn also is known for its anti-inﬂammatory properties
within the human body [58, 59], and its deﬁciency has been
reported to reduce bone density and ductility, resulting in an
increased probability of fracture [8, 9].
To date, there is a signiﬁcant body of research dealing
with single ion substituted CaP materials (as highlighted in
Table 1). However, there are increasing numbers of reports
on the use of co-substituted materials systems in both bulk
powder form and coatings [10, 13, 14, 24, 26, 32, 58–62]. It
has been suggested in the literature that co-substituted CaP
systems may add signiﬁcant value when considered for use
in vivo (when compared to pure HAp and single ion
substituted systems). A number of different deposition
methods have already been investigated to produce co-
substituted Ca-P coatings, including electrochemical
deposition [19, 34], plasma spraying [63], sol-gel methods
[32] and co-blasting [64]. Of the alternative coating tech-
nologies available, radio frequency (RF) magnetron sput-
tering has been shown to be particularly useful for the
deposition of CaP coatings due to the ability of the
technique to provide greater control of the coating’s prop-
erties and improved adhesion between the substrate
and the coating [65–70]. With respect to producing co-
substituted CaP coatings, RF magnetron sputtering allows
co-deposition of multiple different target materials
Table 1 Examples of different ions that have been substituted in CaP
materials
Ion Substitutes for References
Cu2+ Ca2+ [10, 11]
Ag+ Ca2+ [12, 13]
Mg2+ Ca2+ [12, 13]
Zn2+ Ca2+ [10, 14]
Sr2+ Ca2+ [7, 14]
SiO4
4− PO4
3− [15, 16]
La3+ Ca2+ [17, 18]
Al3+ Ca2+ [17, 19]
Fe2+/3+ Ca2+ [14, 17]
F− OH- [10, 20]
SeO3
2− Ca2+ [21]
Ce3+ Ca2+ [22]
Cl− OH− [23, 24]
Na+ Ca2+ [25, 26]
K+ Ca2+ [27, 28]
Ba2+ Ca2+ [29, 30]
CO3
2− OH- or PO4
3− [26, 31]
Mn2+ Ca2+ [32]
Co2+ Ca2+ [33, 34]
Ga3+ Ca2+ [35]
Ti4+ Ca2+ [36, 37]
Eu3+ Ca2+ [38]
Nb5+ PO4
3− [39]
Cd2+ Ca2+ [40, 41]
Y3+ Ca2+ [40, 42]
Li+ Ca2+ [43]
SO4
2− PO4
3− [44]
Ta5+ Ca2+ [45]
Sm2+/3+ Ca2+ [46]
Gd2+ Ca2+ [46]
In3+ Ca2+ [47]
Bi3+ Ca2+ [47]
Zr4+ Ca2+ [48]
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simultaneously and therefore provides an alternative and
simple method to produce co-substituted CaP coatings
[71–73]. Several reports in the literature highlight how it
has already been used to deposit Sr or Si substituted HAp
coatings [70–73]. However, to date, to the best of the
authors’ knowledge, there is no available information on the
utilisation of RF magnetron sputtering as a method to
deposit Sr and Zn co-substituted CaP surfaces, with the
primary objective of creating a surface whereby the con-
centrations of the different ion substitutions can be carefully
controlled in line with requirements.
The present work was undertaken in order to study the
deposition of Sr and Zn co-substituted Ca-P coatings from a
custom designed RF magnetron sputtering facility utilising
two sputtering targets (referred to as sources). Sr and Zn
were chosen for this study as their combined application in
a CaP coating could add signiﬁcant value to such surfaces
when compared to applying the ion substitutions separately.
In particular, the inﬂuence of different target conﬁgurations
on the properties of the Sr and Zn co-substituted sputter
deposited coatings produced at a low discharge power level
(150W) were investigated. A low discharge power level
was chosen for this study as the quality and consistency of
the targets used could be guaranteed throughout the sputter
deposition runs. All of the coatings produced were char-
acterised after post-deposition annealing to 500 °C using
Fourier Transform Infrared Spectroscopy (FTIR), X-Ray
Diffraction (XRD) and X-Ray Photoelectron Spectroscopy
(XPS).
2 Materials and methods
2.1 Synthesis and characterization of pure and ion-
substituted HAp powders
HAp and HAp substituted with 10wt% Sr ([Sr/Ca+ Sr)]
and 10wt% Zn ([Zn/Ca+ Zn)] powders were synthesized
through a standard neutralization route. The experimental
ratios of Ca/P or (Ca+M)/P (where M= Sr or Zn) were
maintained at 1.67. Starting suspensions were prepared by
dissolving Ca(NO3)2·4H2O (puriss. p.a., Sigma-Aldrich,
Germany) and Sr(NO3)2 (puriss. p.a., Sigma-Aldrich, Ger-
many) or Zn(NO3)2·6H2O (98%, reagent-grade, Sigma-
Aldrich, Germany) in deionised H2O. An aqueous solution
of H3PO4 (75%, puriss, Sigma-Aldrich, Germany) was
utilised as a source of (PO4
3−) and was added to the starting
suspensions at a slow addition rate (~0.75 ml/min). The pH
of the synthesis mixture was kept around 9, using 25%
ammonia solution. The synthesis temperature was kept
constant at 45 °C. The precipitates obtained were left
overnight to mature, ﬁltered, and then washed with deio-
nised H2O. Finally, the precipitates were dried at 105 °C for
~24 h, milled and selectively sieved to obtain powders with
particle size less than 100 µm. The HAp powders were
labelled HAp, 10SrHAp and 10ZnHAp, respectively.
The chemical constitutions of the prepared powders were
determined by atomic absorption spectrometry (AAS) and
energy dispersive X-ray spectrometry (EDX) utilising the
following equipment: Varian SpektrAA 880 and Mira/
LMU/Inca Energy 350, respectively. The molar ratios of
(Ca+ Sr)/P and (Ca+ Zn)/P were calculated from the
results obtained. Different functional groups were deter-
mined using Fourier transform infrared spectroscopy (FT-
IR, Varian 800, Scimitar Series). The spectra were recorded
in the range of 400–4000 cm−1 with spectral resolution 4
cm−1 with 30 scans co-added. The phase composition and
crystallinity was analyzed by X-ray diffraction (XRD) uti-
lising a Rigaku Ultima+ XRD system operating at 40 KV
and 30 mA using Cu Kα (λ= 1.5406 Å) radiation. Scans
was recorded over the range from 2Ө= 5° to 60°. For the
phase identiﬁcation the International Centre for Diffraction
Data (ICDD) was used (card #01-072-1243 for HAp). The
Brunauer–Emmett–Teller (BET) method was used to
determine the speciﬁc surface area (SSA) of precipitated
powders by N2 absorption (Quadrasorb-SI Kr, Quanta-
chrome). The samples were degassed at 40 °C for 24 h prior
the analyses. The values of mean sizes of particles of as-
synthesized powders were estimated from the N2 adsorption
isotherms using the BET particle diameter (dBET) from the
following Eq. (1) by assuming the primary particles to be
spherical:
dBET ¼ 6q  SSAð Þ ; ð1Þ
where q is theoretical density of HAp—3.16 g/cm3
(according to ISO 13175-3:2012 Implants for surgery—
Calcium phosphates—Part 3: Hydroxyapatite and beta-
tricalcium phosphate bone substitutes).
2.2 Production and characterization of pure and ion-
substituted HAp coatings
For this study coupons of chemically pure titanium (cpTi),
Titanium International Ltd. (15 mm× 15 mm× 0.5 mm)
were abraded using a succession of 800, and 1200 grade
SiC papers. The coupons were twice sonicated for 10 min
consecutively in acetone, isopropyl alcohol and distilled de-
ionised water. The abraded coupons were then dried thor-
oughly in a convection oven at 70 °C for 12 h. Radio Fre-
quency (RF) magnetron sputtering of the HAp and
substituted HAp coatings was performed using a cluster of
two high vacuum Torus 3 M sputtering sources in a custom
designed system (Kurt J. Lesker Ltd, USA) each operating
with a 13.56MHz RF generator and an impedance matching
network (Huettinger, GmbH, Germany). The coating
J Mater Sci: Mater Med (2017) 28:51 Page 3 of 14 51
nomenclature was deﬁned as highlighted in Table 2. After
sputter deposition, the Ca-P coatings were thermally
annealed. The samples were subjected to a ramp rate of 5 °C
per minute to 500 °C (from room temperature) with a soak
time of 2 h and a ramp rate of 5 °C per minute back down to
room temperature.
Fourier transform infrared (FTIR) spectroscopy of the
samples was carried out using a BIORAD FTS 3000MX
Excalibur series instrument with a PIKE diffuse reﬂectance
infrared Fourier transform spectroscopy (DRIFTS) acces-
sory. X-ray diffraction (XRD) of the samples was carried
using a Bruker D8 Discover Diffractometer ﬁtted with a
Gobel Mirror. A Cu Kα X-ray radiation (λ= 1.540 Å)
source was employed. For the grazing incidence angle XRD
studies of the Ca-P coatings on the titanium coated silicon
substrates the tube angle was set to 0.75°. Scans were
recorded between 2Ө= 24° to 36°. X-ray photoelectron
spectroscopy (XPS) of the samples were carried out using a
Kratos Axis Ultra DLD spectrometer. Spectra were recor-
ded by employing monochromated Al Kα X-rays (hν=
1486.6 electron volts (eV)). Sample charging effects on the
measured BE positions were corrected by setting the lowest
BE component of the C1s spectral envelope to 285.0 eV,
i.e., the value generally accepted for adventitious carbon
surface contamination [68]. Photoelectron spectra were
further processed by subtracting a linear background and
using the peak area for the most intense spectral line of each
of the detected elemental species to determine the % atomic
concentration. Three areas were analysed for each sample.
3 Results
3.1 Powder results
The main characteristics of the precursor powders are
summarised in Tables 3 and 4. The experimental amounts
of Zn and Sr in the powders, evaluated through AAS are
reported as a function of the Zn and Sr content in the
starting solution. It was found that not all of into Sr and Zn
synthesis media added were substituted into the lattice of
HAp. It implies that some of Zn and Sr ions remain in the
precursor solution after precipitation. The differences
between the theoretical and measured Sr and Zn con-
centrations might be due to Sr or Zn complexes Sr(NH3)4
2+
or Zn(NH3)4
2+ formed with the ammonia used for adjusting
pH of the synthesis media [74]. Thus, Sr and Zn substitu-
tions were inhibited, and the resulting materials were Ca-
deﬁcient. Given that the FTIR and XRD results (discussed
below) did not show the presence of any by-products in the
as-synthesized powders, it is most likely that the complexes
were removed by washing the precipitate. Notably, the ratio
between the two cations Sr/(Ca+ Sr) and Zn/(Ca+ Zn) in
the solid products are slightly lower than those in the pre-
cursor solutions. EDX results, as reported in Table 4, shows
that 10SrHAp and 10ZnHAp powders obtained by the
precipitation processes have a (Ca+Sr)/P and (Ca+ Zn)/P
ratio < 1.67. Thus, the powders were found to be sub-
stoichiometric apatite [75]. The Ca/P ratio of the HAp
powder was 1.69, slightly higher than that expected for
stoichiometric HAp [1, 68].
FTIR spectra of the as-synthesized HAp and Sr-, Zn-
substituted HAp powders are shown in Fig. 1a–c, respec-
tively. All of them show the characteristic absorption bands
expected for the HAp powder. The absorption peaks
observed at 3570 and 633 cm−1 are assigned to the vibra-
tional modes of the [OH] group [62, 68]. However, the
resolution and intensity of the absorption peak of the
structural [OH] group at 633 cm−1 observed in the as-
synthesized 10SrHAp and 10ZnHAp, were signiﬁcantly
diminished when compared to the HAp powder, high-
lighting the loss of OH− ions from the unit cell and the
Table 2 Target conﬁguration for sputter deposition
Coating nomenclature Target 1 powder Target 2 powder
HAp HAp HAp
SrHAp 10SrHAp 10SrHAp
ZnHAp 10ZnHAp 10ZnHAp
Sr-ZnHAp 10SrHAp 10ZnHAp
Table 3 Chemical analysis of
the Sr- and Zn-substituted HAp
powders. *M – substituting
cation (Sr for Sr-substituted
HAp, Zn for Zn-substituted
HAp)
Powder Sample M/(Ca+M) in starting
solution
M concentration measured by AAS,
wt.%
M/(Ca+M) in solid
products
10ZnHAp 0.10 7.10± 0.60 0.086
10SrHAp 0.10 5.40± 0.50 0.070
Table 4 Stoichiometry analysis of the HAp and the Sr- and Zn-
substituted HAp powders.
Sample Expected values Calculated values
(Ca+M*)/P Ca/P (Ca+M*)/P Ca/P
HAp – 1.67 1.69 1.69
10SrHAp 1.67 1.59 1.53 1.46
10ZnHAp 1.67 1.54 1.51 1.41
*M substituting cation (Sr for Sr-substituted HAp, Zn for Zn-
substituted HAp)
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apparent substitution of Sr or Zn into the lattice of HAp
[55]. The absorption band observed from 1100 to 1000
cm−1 and absorption peaks at 906, 602, 565 and 475 cm−1
are assigned to the [PO4] groups [62, 69]. The broad (weak)
stretching band from 3600 to 3400 cm−1 and a bending
peak at 1620 cm−1 are attributed to the adsorbed H2O
molecules [60, 62, 66]. Small peaks related to [CO3] groups
were detected at 1450, 1414 cm−1 and 875 cm−1 [72, 73,
76]. The peak observed at 875 cm−1 may also be associated
with HPO4
2− groups. [72, 73]. However, as no other HPO4
2
− were detected in these synthesised materials, the peak at
875 cm−1 is more likely a consequence of related to CO3
2−
groups. The XRD results for the as-synthesized HAp and
Sr-, Zn-substituted powders as shown in Fig. 2a–c,
respectively. The peak positions and relative peak inten-
sities for all of the synthesised powders correspond closely
to those indicated in the International Centre for Diffraction
Data (ICDD) ﬁle #01-072-1243 for HAp [77]. It was
notable that all the synthesised powders exhibited sig-
niﬁcant peak broadening, however, no additional CaP
phases were detected in any of the diffraction pattern
obtained. In the case of the 10SrHAp substituted powder,
the peak positions in the diffraction pattern are shifted to
slightly lower 2-theta (2θ) values, whereas, the peak posi-
tions are relatively unchanged for the 10ZnHAp powder.
The speciﬁc surface area (SSA) of precipitated powders
(m2/g) was observed to increase signiﬁcantly with the
substitution of Ca by both Sr and Zn in the lattice, as
highlighted in Table 5. This corresponds to the expected
decrease in the estimated mean microcrystallite size (dBET,
nm) for the substituted materials when compared to the
HAp powder, as reported in Table 5. These would be in line
with expectations for these materials.
3.2 Coating results
The CaP coatings produced from the HAp, and the different
10SrHAp and 10ZnHAp target combinations were analysed
using FTIR, XRD and XPS, to assess the surface properties
after thermal annealing at 500 °C. The as-deposited CaP and
substituted CaP coatings were not analysed in this study as
previous work by the authors has shown that these surfaces
are amorphous and require thermal annealing in order to
produce crystalline coatings [67–69, 72, 73]. Therefore, all
coatings that are described here are those that have been
annealed to 500 °C only.
In the ﬁrst instance, the FTIR spectrum of the coatings
produced from the HAp targets were indicative of crystal-
line HAp, as shown in Fig. 3a. Well resolved P-O stretching
vibrations were observed as expected between 1100–950
cm−1. O-P-O bending vibrations are also present between
620–560 cm−1, as shown in Table 6 [67–69]. Hydrogen
phosphate bands (HPO4
2−) can also be observed at 1117
and 584 cm−1 [72, 73]. A weak O-H librational band is
observed around 632 cm−1 as a very weak shoulder, with a
further peak associated with O-H groups observed at 3568
cm−1. This peak may be associated with O-H stretching
groups within the ﬁlm [67–69]. The absence of strong OH
functional groups, commonly observed at approximately
632 cm−1 and 3568 cm−1, indicate a degree of dehydrox-
ylation within the CaP crystal structure deposited from the
HAp targets under the conditions employed here. Further-
more, weak CO3
2− bands are observed between 1550–1400
cm−1 and 820–890 cm−1 [72, 76]. The peak observed at
584 cm−1 may also be due to the presence of HPO4
2−
Fig. 1 FT-IR spectra of the as-synthesized a HAp, b 10SrHAp and c
10ZnHAp powders
Fig. 2 XRD patterns of as-synthesized a HAp, b 10SrHAp and c
10ZnHAp powders
Table 5 BET data of the as-synthesized powders
Sample SSA, m2/g dBET, nm
HAp 55.67± 0.58 34.11± 0.04
10SrHAp 70.31± 0.59 27.00± 0.02
10ZnHAp 95.80± 1.28 19.82± 0.03
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groups [72, 73]. For those coatings produced from the two
10SrHAp target conﬁgurations (SrHAp), the phosphate
bands (PO4
2−) and hydrogen phosphate bands (HPO4
2−)
bands are observed in largely similar peak positions as
would be expected for SrHA, with shifting to slightly higher
wavenumbers for most peaks observed [71–73]. Again, the
OH stretching vibration at 3570 cm−1 are poorly resolved
and the OH− librational band typically expected at around
632 cm−1 is absent as can be seen in Fig. 3b and Table 6.
Similar results are also seen for the ZnHAp coatings as was
observed for the SrHAp coatings. However, no obvious
peaks for carbonate or the OH− librational vibration can
be detected, as shown in Fig. 3c and Table 6. The
co-substituted Sr-ZnHAp coating FTIR spectrum is again
very similar to those observed for the SrHAp and ZnHAp
surfaces, however, a weak shoulder indicative of OH−
librational band is again present at around 631 cm−1, as
shown in Fig. 3d and Table 6.
The peaks observed in the XRD patterns for the Ca-P
coatings derived from the HAp targets, as shown in Fig. 4a,
correspond closely to those in the ICDD ﬁle #01-072-1243
for HAp. Furthermore, the intensity of the 002 reﬂection at
25.9° 2θ is higher than would be expected for a HAp
coating, which suggests that this coating may have a 002
preferred orientation and would be line with expectations
for coatings deposited under the conditions employed here
[72, 73]. The XRD pattern for the SrHAp coatings is shown
in Fig. 4b, however, as expected for a Sr-substituted
material, the peak positions are shifted to slightly lower 2-
theta (2θ) values [71–73]. No signiﬁcant peak broadening
was observed for this particular coating. However, there
was a notable change in the relative peak intensities of the
211 and 112 peaks with the addition of Sr to the coatings.
For the ZnHAp coatings, the peak positions and intensities
are very similar to those obtained for the HAp coatings
produced here, with an obvious preferred 002 orientation
again observed as shown in Fig. 4c. The co-substituted Sr-
ZnHAp coating XRD pattern, as shown in Fig. 4d is again
very similar to those observed for the SrHAp coatings, with
a pronounced 002 preferred orientation and a clear differ-
ence in the relative peak intensities of the 211 and 112
peaks. In the case of all the HAp, SrHAp, ZnHAp and Sr-
ZnHAp coatings, no signiﬁcant amorphous background
hump was observed. In addition to this no other Ca-P
phases were detected in the XRD pattern for any of the
coatings.
The XPS results for the SrHAp, ZnHAp and Sr-ZnHAp
coatings are highlighted in Fig. 5a–d, respectively and
Table 7. For the HAp coating, shown in Fig. 5a, peaks
corresponding to Ca2s (438.6 eV), Ca2p3/2 (347.5 eV),
Ca2p1/2 (351.0 eV), P2p (133.5 eV), P2s (191.0 eV), O1s
(531.5 eV), O AugerKLL (764.0 eV) and Ca AugerLMM
Fig. 3 FTIR spectra for a HAp coating, b SrHAp coating, c ZnHAp
coating and d Sr-ZnHAp coating (all annealed to 500 °C)
Table 6 FTIR peak assignments for the HAp, SrHAp, ZnHAp and Sr-
ZnHAp co-substituted coatings
Peak assignment HAp SrHAp ZnHAp Sr-ZnHAp
HPO4
2− (P-O-H) 1117 1122 1120 1124
PO4
3− (P-O) 1080 1082 1078 1079
1018 1020 1020 1020
PO4
3− (P-O) 961 961 962 964
PO4
3− (O-P-O) 601 611 605 605
HPO4
2− (P-O-H) 584 584 584 586
PO4
3− (O-P-O) 566* 565* 566* 565*
PO4
3− (O-P-O) 471*** 475*** 470*** 471***
CO3
2− (C-O) 1550–1400** 1550–1400** – –
CO3
2− (O-C-O)/
HPO4
2− (P-O-H)
875*** 880*** – –
OH− (O-H) 3568 3570 3569 3570
OH− (O-H) 632** – – 631*
*weak shoulder, **very weak shoulder, ***weak band
Fig. 4 XRD patterns for a HAp coating, b SrHAp coating, c ZnHAp
coating and d Sr-ZnHAp coating (all annealed to 500 °C)
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(964.0 eV) are clearly observed and correspond closely to
those reported in the literature for HAp [67–69, 72, 73]. No
other elemental species were detected at least at the detec-
tion limits of the instrument (~0.1 atomic % concentration).
The Ca/P ratio of the custom synthesised HAp derived
coating was calculated at 1.60± 0.01 and is slightly lower
than that expected for stoichiometric HAp, however, it is
line with expectations for coatings produced under the
conditions employed here [67–69]. The peak positions
highlighted in Fig. 5b and in Table 7 for the SrHAp coating
were all in line with those expected for Sr-substituted HAp,
with clear evidence for the presence of Sr highlighted by the
presence of the Sr3p3/2 at 269.5 and Sr3p1/2 at 280.1 eV [72,
73]. The Ca/P and Ca+ Sr/P ratios for the SrHAp coatings
were 1.38± 0.19 and 1.45± 0.22, respectively (as shown in
Table 7). The spectral envelope observed at 133.5 eV con-
sists of an overlap of the Sr3d and P2p peaks because the
Sr3d5/2 (133± 0.5 eV), Sr3d3/2 (135 ± 0.5 eV) and the P2p
(132–133 eV) lines are located so close together. For the
ZnHAp coating, the presence of Zn in the coating is con-
ﬁrmed due to the presence of the Zn3p3/2 at 1022.5 and
Zn3p1/2 at 1045.4 eV as shown in Fig. 5c [78]. The Ca/P
Fig. 5 XPS wide energy survey scans (WESS) for a HAp coating, b SrHAp coating, c ZnHAp coating and d Sr-ZnHAp coating (all annealed to
500 °C)
Table 7 Comparative XPS data for the different HAp and substituted HAp coatings
Sample Peak positions – B.E. (eV) Quantiﬁcation ratios
C1s O1s Ca2p3/2 P2p3/2 / Sr3d5/2 Sr3p3/2 Zn2p3/2 Ca/P Ca+M/P Ca+M/Ca
HAp 285.0 531.5 347.5 133.5 – – 1.60± 0.01 – –
SrHAp 285.0 531.5 347.5 133.5 269.5 – 1.38± 0.19 (Sr) 1.45± 0.22 (Sr) 1.05± 0.02
ZnHAp 285.0 531.3 347.5 133.5 – 1022.5 1.16± 0.08 (Zn) 1.20± 0.08 (Zn) 1.03± 0.01
Sr-ZnHAp 285.0 531.1 347.5 133.5 269.4 1022.4 1.39± 0.12 (Sr) 1.47± 0.13 (Sr) 1.06± 0.01
(Zn) 1.42± 0.12 (Zn) 1.02± 0.01
(Sr+Zn) 1.50± 0.14 (Sr+Zn) 1.08± 0.01
*M substituting cation (Sr for Sr-substituted HAp, Zn for Zn-substituted HAp as indicated in the Table)
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and Ca+Zn/P ratios for the SrHAp coatings were 1.16±
0.08 and 1.20± 0.08, respectively (as shown in Table 7). In
comparison, the wide energy survey scan for the Sr and Zn
co-substituted HAp coating (Sr-ZnHAp), highlighted in
Fig. 5d, shows the presence of peaks for both Sr (Sr3p3/2 at
269.4 and Sr3p1/2 at 280.1 eV) and Zn (Zn3p3/2 at 1022.4
and Zn3p1/2 at 1045.2 eV) [72, 73, 78]. The Ca/P, Ca+ Sr/
P, Ca+ Zn/P and Ca+ Sr+ Zn/P ratios for the Sr-ZnHAp
coatings were 1.39± 0.12, 1.47± 0.13, 1.42± 0.12 and
1.50± 0.14, respectively. If the Ca+M/Ca ratios (where
M= Sr or Zn substituting ion) are also compared for the
different Sr and Zn substituted coatings (as shown in
Table 7), it appears that the Sr levels are comparable
between the SrHAp and Sr-ZnHAp surfaces. A similar trend
was observed for the Zn levels between the ZnHAp and Sr-
ZnHAp surfaces. For the Sr, Zn and Sr-Zn substituted
coatings, no other elemental species were detected within
the detection limits of the instrument.
4 Discussion
The present work was undertaken in order to study the
deposition of Sr and Zn substituted and co-substituted CaP
coatings onto titanium substrates using RF magnetron
sputtering.
Before sputtering the HAp and 10SrHAp and 10ZnHAp
target materials (both 10% substituted with Sr and Zn,
respectively) were analysed using FTIR, XRD EDX and
AAS. The purity, crystallinity and stoichiometry (Ca/P ratio
of 1.69) of the HAp powder was as expected and conﬁrmed
the presence of a slightly calcium rich, carbonated HAp
powder. Despite this, the XRD results highlighted that no
other CaP phases were detected in the custom synthesised
HAp powder. Due to the presence of the signiﬁcant CO3
2−
peaks between 1550–1400 cm−1 and at 875 cm−1 for the
HAp powders, this indicates substitution of both the OH−
and PO4
3− groups by CO3
2− (A-B type substitution) [76].
As no other signiﬁcant HPO4
2− peaks were observed in the
FTIR spectra for the HAp powder, it would be suggested
that the peak at 875 cm−1 was due to the presence of CO3
2−
in this powder sample. Therefore, the results here would
suggest the HAp powder formula to be Ca10[(PO4)6−x
(CO3)x][(OH)2−x(CO3)x [76]. By comparison, the purity
and crystallinity of the 10SrHAp powder were largely as
expected and conﬁrmed the presence of signiﬁcant levels of
Sr-substitution within the HAp lattice. However, the EDX
results clearly show that the 10SrHAp powder synthesised
here have a (Ca+Sr)/P ratio of 1.53 (much less than the
expected value of 1.67). This might be due to the generation
of crystal defects from the ion substitution process [75]. The
corresponding FTIR spectra highlighted that the presence of
Sr in the HAp lattice resulted in signiﬁcant peak broadening
with respect to the PO4
3− peaks between 1200–900 cm−1,
which is indicative of Sr incorporation in the HAp lattice
[72, 73]. The Sr-substituted HAp powder also became more
dehydroxylated as a result of the presence of Sr, with the
OH- stretching and librational bands in the FTIR spectra
around 3570 cm−1 and 632 cm−1 becoming much less
prominent. Peak broadening and dehydroxylation are indi-
cative of Sr incorporation of the HAp lattice. [72, 73, 79].
This usually results in structural disorder along the c-axis
and it is well documented that a lack of hydroxylation
within the HAp lattice affects the degree of atomic ordering
in HAp [80, 81]. Small peaks related to [CO3] groups were
also detected at 1450, 1414 cm−1 and 875 cm−1, which is
indicative of CO3
2− groups, which are partially substituting
for the PO4
3− groups in the structure of HAp (B-type car-
bonated HAp) [58, 76]. Despite this, no signiﬁcant HPO4
2−
peaks were observed in the FTIR spectra for the 10SrHAp
powders as might have been expected for a Sr-substituted
CaP material [72, 73]. Typically, Sr substitution for Ca in
the HAp lattice results in an increase in both CO3
2− and
HPO4
2− groups (especially CO3
2− groups) due to the
increased lattice strain caused by the larger Sr ions [79, 82].
The XRD results for the Sr-substituted powder also high-
lighted that due to the incorporation of Sr into the HAp
lattice, the peak positions shifted to slightly lower 2-theta
(2θ) values. The peaks also exhibited signiﬁcant broadening
as a consequence of Sr substitution, as can be observed in
Fig. 2. This would be in line with expectations and is due to
substitutional strain in the lattice [83, 84]. The XRD results
also highlighted that no other CaP phases were detected in
any of the Sr-substituted powders. Interestingly, for the Sr-
substituted HAp powder used here to produce the sputtering
targets, no pronounced 002 preferred orientation was
observed in the diffraction pattern. Previous studies on Sr-
substituted apatites have shown that as the Sr content in
HAp increases, so does c-axis orientation [71–73].
Similar observations are made for the 10ZnHAp powder
when compared to that of the 10SrHAp powder, whereby
the FTIR spectrum shows the powder material to be dehy-
droxylated (due to the diminished OH- peaks) and con-
taining carbonate ions due to the presence of weak CO3
2− at
1450, 1414 cm−1 and 875 cm−1, which is again indicative
again of B-type carbonated HAp (albeit 10ZnHAp here).
The 10ZnHAp powder is also calcium deﬁcient, with EDX
giving a Ca+Zn/P ratio of only 1.51, much lower than that
expected in this case (as highlighted in Table 4). The XRD
results for the 10ZnHAp powders were as expected, with
peaks corresponding closely to that of HAp (ICDD File#
01-072-1243). No phase impurities were detected in the
10ZnHAp powder, however, signiﬁcant peak broadening
was observed and a typical random crystallite orientation
was observed for both the 10SrHAp and 10ZnHAp powders
synthesised here and consequently used to produce the
51 Page 8 of 14 J Mater Sci: Mater Med (2017) 28:51
sputtering targets in this body of work. The XRD results for
the 10SrHAp and 10ZnHAp powders corroborate those
results highlighted from the EDX and FTIR analyses con-
ﬁrming that the 10SrHAp and 10ZnHAp powders contains
appreciable levels of Sr and Zn, with Sr and Zn substituting
for Ca in the HAp lattice. These results also suggest that the
substituted powder synthesised for this study are non-stoi-
chiometric, i.e. Ca-deﬁcient apatite containing CO3
2− sub-
stitutions, with CO3
2− only substituting for PO4
3− (B-type
carbonated HAp) [75, 76]. In both cases this would suggest
a possible Ca10−X−Y−Z(M)Y(PO4)6−X−Z(CO3)Z(OH)2−X,
(where M is either Sr or Zn substituting for Ca in the HAp
lattice), as this allows for both a Ca/P and Sr+Ca/P lower
than 1.67. Further to this, these ﬁndings also indicate
increasing structural disorder or reduction in crystallite sizes
as a consequence of Zn or Sr substituting for Ca in the HAp
lattice. It was reported that the incorporation of a small
amount of Zn into the HAp structure induces an evident
reduction in the degree of crystallinity of the apatite phase,
which leads to the inability of the structure to host greater
amounts of Zn [85]. These observations are supported by
results of BET analysis, summarized in Table 5. The SSA
measurements show a signiﬁcant reduction of BET particle
sizes due to the incorporation of Zn into the apatite crystal
structure. However, in the case of 10SrHAp powders, the
results of BET analysis show an increased particle size
when compared to that of 10ZnHAp. It is well documented
that the Zn, Ca, and Sr ionic radii are, 0.074, 0.099, and
0.112 nm, respectively [62, 74]. The difference between the
Sr and Ca ionic radii is noticeably lower as is the difference
between the Zn and the Ca ionic radii. Therefore, the Zn-
containing apatite is characterized by considerably higher
strains and distortions of the structure [75].
After sputtering the HAp, 10SrHAp and 10ZnHAp
materials onto the titanium substrates (using various dif-
ferent target conﬁgurations, as highlighted in Table 2) dis-
tinct changes were observed in their surfaces properties as
determined using FTIR, XRD, and XPS analyses. The
coatings in each case were annealed to 500 °C after
deposition due to the as-deposited coatings being amor-
phous in nature. This is a consequence of the low sputtering
power employed in this study (150W) [67–69, 72, 73].
Others have shown that crystalline coatings can be pro-
duced by increasing the RF power [65]. However, for the
purposes of this study a lower deposition power is delib-
erately employed as coatings produced using low power
have been shown to contain only hydroxyapatite and no
other additional Ca-P phases or by-products [67–69]. This
would be in line with expectations of the various interna-
tional standards that cover hydroxyapatite powders and
coatings (ASTM 1185-03(2014), ASTM 1609—(08)2014
and ISO 13779 (Parts 2 and 3)). Furthermore, no impurities
were detected on the surface of any of these coatings (as
conﬁrmed by the analyses undertaken here). The HAp
derived coatings annealed to 500 °C has a Ca/P ratio of
1.60± 0.01, which is slightly lower than would be expected
for a sputter deposited coating under the conditions
employed here [67–69]. However, it should be noted that
previous studies where Sr was sputter depicted onto tita-
nium surfaces, three sputtering targets rather than two (as
utilised here) were employed, and the source HAp was
custom synthesised, as compared to the commercially
available HAp powders used previously by the authors [68–
70, 72, 73]. This may account for the slightly lower coating
stoichiometry observed here for the HAp coatings. The
XRD results for the same coatings produced from the two
HAp targets also highlighted the expected 002 preferred c-
axis orientation, as determined by XRD analyses. Typically,
002 preferred orientation in HAp results in an elevated Ca/P
ratio [82]. To add to this, the FTIR results highlight that
these coatings produced from the HAp precursor powders
contain trace amounts of CO3
2− within the lattice, due to the
presence of peaks between 1550–1400 cm−1 and 875 cm−1,
as highlighted in Fig. 3a and Table 6. There is evidence for
the presence of signiﬁcant HPO4
2− functional groups due to
the strong peaks at 1122 and 582 cm−1 (and possibly the
peak at 875cm−1). Furthermore, the HAp derived coatings
are also dehydroxylated. Typically, it is expected that if
HAp is dehydroxylated, then the charge balance within the
crystal structure must therefore be provided by other means.
HAp is understood to undergo carbonate (CO3
2−) sub-
stitution within the crystal lattice at multiple sites [76, 83].
Most notably, A type substitution (for OH− groups), B type
substitutions (for PO4
3− groups), or both (AB) substitution
are acknowledged as providing for charge balance in the
lattice structure of HAp [76, 83]. The presence of Ca10−X−Y/2
[HPO4)x(PO4)]6−X−Y(CO3)Y(OH)2−X−Y species could be
suggested for this coating, however, a combination of cal-
cium deﬁcient hydroxyapatite (CDHA) material [Ca10−X
[(PO4)6–X(HPO4)X](OH)2−X and A-B substituted materials
cannot be ruled out [Ca10[(PO4)6−x(CO3)x][(OH)2−x(CO3)x],
which may help to explain the lower Ca/P ratio obtained for
this surface via XPS analysis. Typically, CDHA results in a
material that has a Ca/P ratio less than 1.67 [80].
In comparison, the XPS results for the SrHAp coatings
were in line with expectations for a Sr-substituted HAp
coating and are similar to those reported previously [72,
73]. Peaks for Sr3p3/2 and Sr3p1/2 can be clearly observed
around 269.6 and 280.1 eV in addition to the expected
peaks for a CaP material [72, 73]. Figure 5b shows a
representative wide energy survey spectra and high reso-
lution spectra for the SrHAp coatings. The Ca/P ratios (and
corresponding Ca+ Sr/P ratio) for the same coatings were
1.38± 0.19 and 1.45± 0.22, respectively, as reported in
Table 7. The Ca/P ratio reduces signiﬁcantly for the SrHAp
coatings when compared to the HAp surfaces, as might
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have been expected with the incorporation of Sr for Ca in
the HAp lattice. This is corroborated by the Ca+Sr/P ratio
as reported in Table 7. Furthermore, the Sr content of the
coatings deposited in previous studies were lower than that
of the original precursor target material, and the same trend
is observed in this study [72, 73]. The corresponding FTIR
spectra highlighted that for the SrHAp coating there was
signiﬁcant peak broadening for the PO4
3− peaks between
1200–900 cm−1. These peaks are also seen to shift to
slightly lower wavenumbers and are dehydroxylated, both
characteristics which are indicative of Sr substituting for Ca
in the HAp lattice [72, 73]. CO3
2− peaks are also detected in
the FTIR spectrum for this coating, with the peaks positions
observed indicating substitution of both the OH− and PO4
3
− groups by CO3
2− (A-B type substitution) [76]. Further to
this, HPO4
2− bands were also clearly observed in the FTIR
spectra for SrHAp coatings. It is expected that as Sr sub-
stitutes for Ca in the HAp lattice an increase in both CO3
2−
and HPO4
2− groups (especially CO3
2− groups) should be
observed, due to the increased lattice strain caused by the
larger Sr ions as highlighted previously [86, 87]. The cor-
responding XRD results for SrHAp coatings highlight that
they have peak positions that are shifted to slightly lower 2-
theta (2θ) values with addition of Sr, as can be observed in
Fig. 4. In addition the XRD results also show that the
SrHAp coatings exhibit signiﬁcant preferred 002 c-axis
orientation, when compared to the HAp coatings and the
10SrHAp precursor powder. The intensity of the 002 peak
(and therefore the 002 c-axis orientation) also appears to
increase relative to the other peaks (namely the 211 peak).
There is also a change in the relative peak intensities of the
211 and 112 peaks with increasing Sr content, as shown in
Fig. 4b for the SrHAp surfaces. These observations would
be in line with previous studies on Sr-substituted HAp,
whereby it has been shown that as the Sr content in HAp
increases, so does c-axis orientation [72, 73]. Considering all
the results obtained here, this could suggest a formula such as
Ca10−X−Y/2[HPO4)X(PO4)]6−X−Y(CO3)Y(OH)2−X−Y) for the
SrHAp coating, given the presence of both the CO3
2−
and HPO4
2− groups, the apparent dehydroxylation of the
coatings and the low Ca/P and C+Sr/P ratios.
In comparison, the XPS results for the ZnHAp surfaces
conﬁrmed the presence of Zn in these coatings as high-
lighted by WESS and Table 7. The Ca/P ratios (and cor-
responding Ca+Sr/P ratio) for the same coatings were 1.16
± 0.08 and 1.20± 0.08, respectively, as reported in Table 7.
The Ca/P ratio is signiﬁcantly lower for the ZnHAp coat-
ings when compared to both the HAp and SrHAp surfaces.
The FTIR results for the ZnHAp coatings indicate that the
coatings are dehydroxylated, have obvious HPO4
2− groups,
but in this case, contain no real trace of any CO3
2− groups,
as was observed for the HAp and SrHAp coatings. The
XRD pattern obtained for this coating type is largely similar
to that of HAp, with some preferred orientation observed,
albeit to the lesser extent that the SrHAp surfaces. The
preferred orientation observed in sputter deposited coatings,
such as those deposited here, is well documented and in this
case for the ZnHAp coatings the preferred orientation may
be a consequence of the deposition parameters employed, as
opposed to the incorporation of Zn into the HAp lattice [67–
69]. No evidence for preferred orientation in Zn substituted
apatites has been found in the previous literature [78, 85].
Some do report shifting of the peaks to higher 2θ values
in the XRD patterns for Zn substituted materials; however,
that was not observed here [88]. Typically the substitution
of Zn into HAp results in a decrease of both a and c
lattice parameters; however, varying points of view on this
do exist in the literature [78, 85] and this is beyond the
scope of this particular study. Therefore, the results here
would indicate that the formula for the ZnHAp coating may
be Ca10−X−Y(Zn)Y(HPO4)X(PO4)6−X(OH)2−X, given that
this allows for low Ca/P and Ca+Zn/P ratios and
the apparent lack of CO3
2− in the lattice. Furthermore,
the apparent lack of hydroxylation, as observed in
the FTIR spectrum, provide clear evidence (along with the
XRD and XPS) that Zn has substituted for Ca in the ZnHAp
coatings.
The results for the co-substituted Sr-ZnHAp coatings
show many similarities to those obtained for both SrHAp
and and ZnHAp surfaces and indicate that both Sr and Zn
have been successfully substituted for Ca in the Sr-ZnHAp
lattice. The reported Ca/P ratio from the XPs analyses was
1.39± 0.12, with Ca+Sr/P and Ca+ Zn/P ratios of 1.47±
0.13 and 1.45± 0.12, respectively, as reported in Table 7.
These results taken in combination with the Ca+ Sr+ Zn/P
ratio of 1.50± 0.14 clearly and the WESS in Fig. 5d sug-
gests the presence of both Sr and Zn in the co-substituted
coatings. Further evidence of the successful co-substitution
of the Sr-ZnHAp coatings is provided by the apparent lack
of hydroxylation in the FTIR results, as highlighted in
Fig. 3d and Table 6. Again, as with the Zn-HAp coatings,
the co-substituted surfaces have obvious HPO4
2− groups in
the FTIR spectra but no real evidence of any CO3
2− groups.
The corresponding XRD pattern in Fig. 4d also shows
shifting of the peaks to slightly lower 2θ values, along with
strong 002 preferred orientation, which has been shown to
be a consequence of Sr substituting for Ca in the lattice.
This, along with the changes in the relative peak intensities
of the 211 and 112 peaks in the XRD pattern, and the lack
of hydroxylation and PO4
3− peak broadening from the
FTIR analyses of the Sr-ZnHAp surfaces, suggest c-axis
orientation and apparent disorder within the lattice of this
coating. This is a direct consequence of simultaneous sub-
stitution of Sr and Zn for Ca in the lattice. As such, the
suggested formula for the co-substituted Sr-ZnHAp coating
produced here could be Ca10−X−Y(M)Y(HPO4)X(PO4)6−X
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(OH)2−X, (with M denoting both Sr and Zn ions substituting
for Ca in the lattice).
If the Ca+M/Ca ratios (M is the substituting metal ion)
are also taken into consideration here, the levels of Sr in the
SrHAp and Sr-ZnHAp surfaces are comparable (1.05 ± 0.02
and 1.06± 0.01, respectively, as shown in Table 7). This is
despite the difference in the number of targets used for each
deposition run (two 10SrHAp targets for the SrHAp coating
and one for the Sr-ZnHAp coating). A similar trend is
observed for the Zn containing coatings (Ca+M/Ca), with
the levels of Zn in the ZnHAp and Sr-ZnHAp surfaces
reported as 1.03± 0.01 and 1.02± 0.01, respectively. By
comparison, the Sr-ZnHAp coating has a Ca+ Sr+ Zn/Ca
ratio of 1.08± 0.01, which clearly corroborates the suc-
cessful incorporation of both Sr and Zn into the co-
substituted coating. Clearly these results for the SrHAp,
ZnHAp and Sr-ZnHAp coatings, highlighted from the XPS
XRD and FTIR analyses conﬁrm that they contain appre-
ciable levels of Sr, Zn or Sr and Zn, with Sr and Zn sub-
stituting for Ca in the HAp lattice and that no other Ca-P
phases or impurities (such as SrCO3), were detected for any
of the substituted coatings in this study. Previous similar
work undertaken by Ozeki et al. highlighted the presence of
additional unwanted CaP phases after sputtering from Sr-
doped HAp targets [71]. As highlighted previously, the
coatings produced here were deposited using distinctly
different experimental conditions, and as such it might be
expected that different results were observed between the
two studies. Most notably, given the relatively low sput-
tering power employed in this study it is less likely that all
of the Sr and Zn atoms have the required energy or
momentum to reach the substrate surface (in line with the Sr
and Zn content of the sputtering targets. This has been
described previously in the literature [71–73]. It has been
suggested that the incorporation of Zn into the HAp lattice
distorts the crystal lattice and hinders HAp crystal growth,
and this may be inferred here from the low Ca/P and Ca +
Zn/P ratios for the 10ZnHAp powder and ZnHAp coatings
[78, 85]. This has been suggested to be a consequence of the
mismatch between the size of the smaller Zn2+ ion
(0.074nm) and that of Ca2+ (0.099 nm). Despite this, it is
apparent from the results obtained here that RF magnetron
sputtering can be successfully employed to sputter deposit
ZnHAp, SrHAp and co-substituted Sr-ZnHAp coatings. Of
particular interest here is the fact that in all cases here, the
coatings produced had a distinct 002 preferred orientation
(albeit more pronounced for the Sr containing coatings
(SrHAp and Sr-ZnHAp). Previous work by others has
shown that a preferred 002 orientation can enhance the
cellular response in vitro, in particular for mesenchymal
stem cells (MSC) [82]. This is most likely a consequence of
the deposition parameters utilised here during sputtering,
but this, with the combined therapeutic potential of Sr and
Zn in the co-substituted surfaces opens up new opportu-
nities to develop coatings that have signiﬁcant in vitro and
in vivo capability, beyond that already available. To date,
there are very few studies that have considered the use of
co-substituted Sr and Zn CaP materials in the literature [14,
62, 89], with most of the work focused towards potential co-
substitutions of Mg and Sr or other ion combinations for
antibacterial applications [13, 19, 23, 26, 32, 58, 61, 62,
90]. To the knowledge of the authors, this is the ﬁrst suc-
cessful attempt to produce Sr and Zn co-substituted HAp
coatings via sputtering (and also Zn substituted HAp coat-
ings as well). Given the obvious ﬂexibility that sputtering
provides, the development of multi-ion substituted CaP
coatings is a real possibility. In the case of the co-
substituted coatings produced here, previous studies have
highlighted the positive effect of Sr-substitution in HAp,
both in vitro and in vivo through enhancing osteoblast
activity (proliferation), differentiation, and reducing osteo-
clast activity [7, 8, 89]. Add to this the fact that Zn has been
shown to stimulate bone growth and mineralisation, lowers
osteoclast activity like Sr, and has possible anti-
inﬂammatory and antibacterial properties [7, 8, 49], the
possibilities of easily delivering sputter deposited coatings
with these combined properties offers signiﬁcant advan-
tages over single ion substitutions. However, detailed
in vitro and in vivo studies would need to be conducted on
these coatings in order to verify these ﬁndings and to study
the effects of different ion concentrations when co-
substituted in HAp coatings.
5 Conclusions
The aim of this particular work was to study the feasibility
of using RF magnetron sputtering to deposit Sr, Zn and Sr-
Zn co-substituted HAp coatings. In particular, the inﬂuence
of different target conﬁgurations on the properties of the
substituted sputter deposited coatings produced at a low
discharge power level (150 W) were investigated. The
results presented herein demonstrate that RF magnetron
sputtering can be used to produce co-substituted Sr-ZnHAp
coatings, and that none of the coatings produced contained
any other impurity CaP phases, with XRD data showing
peaks corresponding to that of ICDD ﬁle #01-072-1243 for
HAp, albeit shifted to lower 2θ values due to the incor-
poration of Sr into the HAp lattice for Ca for the SrHAp and
Sr-ZnHAp coatings. All of the coatings are calcium deﬁ-
cient and exhibit preferred 002 orientation, which is more
pronounced for the Sr-containing surfaces. These are all
properties that have been highlighted in the literature as
having the potential to have a positive inﬂuence on the
osteoblast response. RF magnetron sputtering therefore
offers a means to control the attendant surface properties of
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Sr, Zn and Sr-Zn co-substituted HAp, such as the crystal-
linity, stoichiometry and phase purity. However, these
surfaces would need to be investigated by rigorous in vitro
and in vivo testing to provide further evidence of their
potential to enhance osteoconduction, osteoinduction and to
be osteogenic by more closely mirroring the complex
chemistry of bone. This could be achieved with the poten-
tial added beneﬁt of being anti-inﬂammatory and anti-
bacterial, and delivering the next generation of biomaterials
for orthopaedics.
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